불임 검사 기기 시장 규모, 점유율 및 동향 분석 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Fertility Testing Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

US $ 5,950 ￦ 8,957,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,462,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,473,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

불임 검사 기기 시장 요약

세계의 불임 검사 기기 시장 규모는 2025년에 25억 4,000만 달러로 추정되며, 2033년까지 38억 7,000만 달러에 달할 것으로 예측됩니다.

2026-2033년 연평균 복합 성장률(CAGR) 5.5%를 나타낼 것으로 예측됩니다. 불임 치료에 대한 관심 증가, 출산 연령의 지연, 라이프스타일의 변화, 가정용 검사 장비의 기술 발전, 재택 및 비침습적 검사에 대한 선호 등이 업계 성장을 이끄는 주요 요인으로 꼽힙니다.

또한 체외수정(IVF) 및 기타 보조생식술(ART) 시술 증가는 불임 치료 기기를 이용한 임신 전 모니터링을 촉진하여 시장 성장을 가속화하고 있습니다. 많은 여성들이 커리어 우선순위, 고등교육, 개인적 목표를 위해 가족을 갖는 시기를 늦추고 있습니다. 부모가 되는 시기를 늦추면 불임에 영향을 미칠 수 있으며, 생식 건강 모니터링에 대한 관심이 높아지고 있습니다.

출산 연령의 지연 외에도 생활습관 요인도 남녀 모두의 생식 건강에 큰 영향을 미칩니다. 높은 스트레스 수준, 불규칙한 수면 패턴, 부적절한 식습관, 운동 부족, 흡연은 남성과 여성의 생식력을 감소시킵니다. 남성의 흡연은 정자 수, 운동성, 정액의 질 저하와 관련이 있으며, 여성의 경우 난소 예비력과 임신율에 영향을 미칩니다. 예를 들어 세계금연행동계획(Global Action to End Smoking)에 따르면 2022년 기준 인도에서는 15세 이상 인구 중 약 2억 5,300만 명(남성 2억 2,000만 명, 여성 5,350만 명)이 담배 제품을 사용하고 있습니다. 이러한 생활습관상의 문제로 인해 많은 개인들이 가정용 비침습적 불임 검사 기기를 통해 적극적으로 생식 건강을 관리하게 되었습니다.

또한 전 세계에서 불임 증가 추세는 남녀 모두 불임 검사 장비에 대한 수요를 더욱 증가시키고 있습니다. 2023년 발표된 WHO 보고서에 따르면 전 세계 성인 인구의 약 17.5%, 전 세계 6명 중 1명이 불임을 경험하고 있으며, 이를 해결하기 위해 필요한 사람들에게 저렴한 가격의 고품질 의료에 대한 접근성을 확대하는 것이 시급하다는 점을 강조하고 있습니다. 요인으로는 호르몬 불균형, 여성의 다낭성난소증후군(PCOS) 등 생식기 질환, 남성의 정자 질 저하 등을 꼽을 수 있습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 불임 검사 기기 시장 변수, 동향 및 범위

제4장 불임 검사 기기 시장 부문 분석 : 제품별(2021-2033년)

제5장 불임 검사 기기 시장 부문 분석 : 용도별(2021-2033년)

제6장 불임 검사 기기 시장 부문 분석 : 최종 용도별(2021-2033년)

제7장 불임 검사 기기 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도

KSA

영문 목차

영문목차

Fertility Testing Devices Market Summary

The global fertility testing devices market size was estimated at USD 2.54 billion in 2025 and is expected to reach USD 3.87 billion by 2033, growing at a CAGR of 5.5% from 2026 to 2033. Rising awareness about fertility health, delayed parenthood and lifestyle changes, technological advancements in home testing devices, and preference for at-home and non-invasive testing are some of the factors driving industry growth.

Furthermore, the growth of IVF and other ART procedures encourages pre-conception monitoring using fertility devices, thereby escalating market growth. Many women are choosing to start families later due to career priorities, higher education, and personal goals. Delaying parenthood can affect fertility, leading to increased interest in monitoring reproductive health.

In addition to delayed parenthood, lifestyle factors significantly impact reproductive health for both men and women. High stress levels, irregular sleep patterns, poor dietary habits, limited physical activity, and smoking reduce fertility in men and women. Smoking in men has been linked to reduced sperm count, motility, and overall semen quality, while in women it affects ovarian reserve and conception rates. For instance, as per the Global Action to End Smoking, in 2022, approximately 253.0 million individuals (200.2 million males and 53.5 million females) aged 15 and above were users of tobacco products in India.These lifestyle challenges have led many individuals to actively monitor their reproductive health through home-based and non-invasive fertility testing devices.

Moreover, the rising prevalence of infertility globally has further increased demand for fertility testing devices for both men and women. According to a WHO report published in 2023, approximately 17.5% of the adult population, about 1 in 6 worldwide, experiences infertility, highlighting the urgent need for increased access to affordable, high-quality care for those in need. Contributing factors include hormonal imbalances, reproductive disorders such as polycystic ovary syndrome (PCOS) in women, and declining sperm quality in men.

Global Fertility Testing Devices Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global fertility testing devices market report-based on product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Ovulation Prediction Kits
• Fertility Monitors:
• Male Fertility Testing Devices
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Female Fertility Testing
• Male Fertility Testing
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Home Care Settings
• Hospitals
• Fertility Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Fertility Testing Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Delayed parenthood and changing family planning trends
    • 3.2.1.2. Increased prevalence of lifestyle-related fertility issues
    • 3.2.1.3. Growing adoption of at-home fertility testing
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Social Stigma Associated with Fertility Testing
    • 3.2.2.2. Accuracy and Reliability Concerns
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis

Chapter 4. Fertility Testing Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

• 4.1. Fertility Testing Devices Market: Product Movement Analysis and Market Share
• 4.2. Fertility Testing Devices Market: Product Segment Dashboard
• 4.3. Ovulation prediction kits
  • 4.3.1. Ovulation prediction kits market, 2021 - 2033 (USD Million)
• 4.4. Fertility monitors
  • 4.4.1. Fertility monitors market, 2021 - 2033 (USD Million)
• 4.5. Male fertility testing devices
  • 4.5.1. Male fertility testing devices market, 2021 - 2033 (USD Million)

Chapter 5. Fertility Testing Devices Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Fertility Testing Devices Market: Application Movement Analysis and Market Share
• 5.2. Fertility Testing Devices Market: Application Segment Dashboard
• 5.3. Female fertility testing
  • 5.3.1. Female fertility testing market, 2021 - 2033 (USD Million)
• 5.4. Male fertility testing
  • 5.4.1. Male fertility testing market, 2021 - 2033 (USD Million)

Chapter 6. Fertility Testing Devices Market Segment Analysis, By End-Use, 2021 - 2033 (USD Million)

• 6.1. Fertility Testing Devices Market: End-Use Movement Analysis and Market Share
• 6.2. Fertility Testing Devices Market: End-Use Segment Dashboard
• 6.3. Home care settings
  • 6.3.1. Home care settings market, 2021 - 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market, 2021 - 2033 (USD Million)
• 6.5. Fertility clinics
  • 6.5.1. Fertility clinics market, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others market, 2021 - 2033 (USD Million)

Chapter 7. Fertility Testing Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional marketplace: Key takeaways
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market position analysis, 2025
• 8.4. Company Profiles
  • 8.4.1. viO HealthTech Inc
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Accuquik
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. SPD Swiss Precision Diagnostics GmbH
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Tempdrop
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Inito Health Tech Private Limited
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Mira
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. YO Home Sperm Test
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Geratherm Medical AG
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. bioZhena Corporation
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Eli Health
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives

관련자료